Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer-Reference-Cited by-同舟云学术

Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer

Published:2019-02 Issue: Volume:295 Page:93-101
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Shapira-Furman Tovi,Serra Riccardo,Gorelick Noah,Doglioli Marisol,Tagliaferri Valentina,Cecia Arba,Peters Michael^ORCID,Kumar Awanish,Rottenberg Yakir,Langer Robert,Brem Henry,Tyler Betty^ORCID,Domb Abraham J.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Overcoming the blood–brain tumor barrier for effective glioblastoma treatment;van Tellingen;Drug Resist. Updat.,2015

2. Epidemiologic and molecular prognostic review of glioblastoma;Thakkar;Cancer Epidemiol. Biomark. Prev.,2014

3. Molecular diagnostics of gliomas: state of the art;Riemenschneider;Acta Neuropathol.,2010

4. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme;McGirt;J. Neurosurg.,2009

5. Current status and future therapeutic perspectives of glioblastoma multiforme (GBM) therapy: a review;Anjum;Biomed. Pharmacother.,2017

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative DFT study of borophene as a promising drug delivery vehicle for carmustine and nitrosourea anti-cancer drugs;Chemical Physics Letters;2024-12

2. 3D Printed Implants for Long‐Acting Drug Delivery;3D Printing of Pharmaceutical and Drug Delivery Devices;2024-05-13

3. Stimuli-sensitive polymer prodrug nanocarriers by reversible-deactivation radical polymerization;Chemical Society Reviews;2024

4. Recent advances towards overcoming the blood–brain barrier;Drug Discovery Today;2023-10

5. Implantable microdevices for treating brain tumors;Device;2023-10